Commercial execution for complex healthcare growth
Q22 helps companies turn strategic ambition into commercial progress, from European market entry and business development to venture building, partnerships and operational execution.
For founders, scale ups, investors and international companies that need senior commercial direction, practical execution and the right network to move forward in Europe.
Interim Business Development
Senior commercial capacity for positioning, pipeline building, customer engagement and deal development.
EU Market Entry
Support for international companies entering Europe with the right commercial, regulatory and operational setup.
Startup & Venture Building
Guidance from concept, IP and funding to licensing, market access and commercialization.
Partner Network & Execution
Access to trusted partners across legal, regulatory, quality, CDMO, logistics, repair and administration.
Strategy only matters when it moves the business forward
Many healthcare companies know where they want to go, but lack the commercial route, local network or senior execution capacity to get there.
Q22 works at the point where strategy becomes practical. The focus is on commercial choices, customer access, partner structure, market entry, deal development and execution discipline.
What Q22 does
Q22 supports companies that need clarity, traction and experienced support in complex healthcare related markets.
- Business development and commercial execution
- European market entry and partner selection
- Commercial positioning and go to market strategy
- Startup, scale up and venture support
- Strategic partnerships, licensing and distributor setup
- Operational partner network across the value chain
Proven in complex healthcare markets
Q22 is built on practical experience in markets where credibility matters, timelines are long and execution failure is expensive.
Experience shaped by leading healthcare companies
Q22 builds on hands on commercial, market access and business development experience across pharma, MedTech, medical nutrition and health ingredients, including work with leading international healthcare companies.
Services that connect direction with execution
Q22 supports companies that need senior commercial thinking, practical execution and access to the right partners across the healthcare value chain.
Business Development & Go To Market
Senior support for positioning, value proposition development, target mapping, customer engagement, pipeline building and deal development.
European Market Entry & Operational Setup
Support for international companies entering Europe, from market selection and local setup to regulatory, quality, logistics, repair, returns, invoicing and partner coordination.
Venture Building, Partnerships & Funding
Hands on guidance for startups and scale ups, from concept, IP, business strategy and funding to licensing, strategic partnerships and commercialization.
Entering Europe requires more than a distributor
Many international companies underestimate the complexity of launching in Europe. Success requires market selection, regulatory understanding, operational setup, partner structure and local credibility.
Q22 helps companies build a practical route into Europe, from first market selection to partner network, customer access and day to day execution.
- Market selection and commercial entry strategy
- European partner and distributor search
- Legal, office and administration setup through trusted partners
- Regulatory, quality and permit coordination
- Logistics, fulfillment, returns and repair processes
- Customer access and business development
Relevant experience across the healthcare value chain
Q22 brings experience from pharma, MedTech, medical nutrition, health ingredients, market access, licensing, business development and venture building.
Pharma & Health Ingredients
Built and commercialized an EU GMP certified analytical pharma lab and API platform based on natural compounds.
MedTech & Drug Delivery
Worked with global MedTech and biomaterials companies on commercial development, licensing and partnerships.
Medical Nutrition & Market Access
Experience in hospital sales, reimbursement, payer dynamics and healthcare stakeholder management.
Venture Building
Raised funding, built companies, developed IP driven platforms and supported technologies towards patient use.
About Q22
Q22 was founded by Ivo Schefman, a senior commercial operator with more than 20 years of experience across pharma, MedTech, medical nutrition, health ingredients and healthcare innovation.
Ivo combines strategic thinking with hands on execution. His experience includes fundraising, business development, licensing, market access, European commercialization, GMP related processes and building partner networks across the healthcare value chain.
Make contactHow Q22 works
- Clarify the real commercial challenge
- Define the target customer and decision process
- Build the route to market
- Select the right partners and capabilities
- Execute with senior hands on support
Let’s discuss your next move
Are you entering Europe, building a healthcare venture, looking for senior business development support or searching for the right commercial partners?
Q22 is based in Maastricht, The Netherlands and works across Europe, EMEA and international market entry.
Contact
For questions, introductions or a first discussion, please contact Q22 directly by email.